BetterLife Pharma (BETRF) Operating Income (2015 - 2019)
BetterLife Pharma (BETRF) posted quarterly Operating Income of -$1.2 million for Q2 2019, up 13.72% year-over-year from -$1.1 million in Q2 2018, and up 11.6% quarter-over-quarter from -$1.4 million in Q4 2018.
BetterLife Pharma (BETRF) Operating Income (2015 - 2019) Analysis & Trends
BetterLife Pharma's Operating Income history runs 5 years deep, the most recent figure standing at -$1.2 million for Q2 2019.
- In Q2 2019, Operating Income rose 13.72% year-over-year to -$1.2 million; the TTM figure through Apr 2019 stood at -$5.3 million (down 128.78% YoY), while the FY2026 annual figure was -$1.2 million, up 67.11% from the prior year.
- Operating Income for Q2 2019 stood at -$1.2 million, up from -$1.4 million in the prior quarter.
- The five-year high for Operating Income was -$7842.0 in Q4 2015, with the low at -$6.8 million in Q1 2016.
- The 5-year median for Operating Income is -$1.2 million (2016), against an average of -$1.5 million.
- The sharpest annual moves came in 2016 and 2017: Operating Income tumbled 8702.65% in 2016, then jumped 91.43% in 2017.
- BetterLife Pharma's Operating Income stood at -$7842.0 in 2015, then sank by 8702.65% to -$690304.0 in 2016, then surged by 63.96% to -$248755.0 in 2017, then tumbled by 467.55% to -$1.4 million in 2018, then rose by 11.6% to -$1.2 million in 2019.
- Business Quant data shows BETRF's Operating Income at -$1.2 million in Q2 2019, -$1.4 million in Q4 2018, and -$1.2 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | -426,847.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2019 | -1.25 Mn |
| Oct 31, 2018 | -1.41 Mn |
| Jul 31, 2018 | -1.18 Mn |
| Apr 30, 2018 | -1.45 Mn |
| Jan 31, 2018 | -330,324.00 |
| Jul 31, 2017 | -248,755.00 |
| Apr 30, 2017 | -285,518.00 |
| Jan 31, 2017 | -822,138.00 |
| Oct 31, 2016 | -690,304.00 |
| Jul 31, 2016 | -1.18 Mn |
| Apr 30, 2016 | -3.33 Mn |
| Jan 31, 2016 | -6.79 Mn |
| Oct 31, 2015 | -7,842.00 |
| Jul 31, 2015 | -2.36 Mn |
| Apr 30, 2015 | -1.16 Mn |